SOX5 and neoplasm: We observed a weakly positive correlation of SOX5 and MITF expression in the BRAF wildtype subgroup (Pearson’s correlation r = 0.18), and weakly negative correlation in the BRAF mutated subgroup (PCC r = -0.13) hinting for a stronger regulatory involvement of SOX5 on MITF expression in the tumor cells with BRAF mutation.